Informed consent in cancer clinical drug trials in China: a narrative literature review of the past 20 years

BACKGROUND: Although the number of cancer clinical drug trials is increasing rapidly in China, issues concerning informed consent in this research context are understudied. By performing a narrative literature review, we aim to describe the current situation and identify the most salient challenges...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xing, Lu, Xiaoran, Zhou, Wei, Hahne, Jessica, Khoshnood, Kaveh, Shi, Xiaoting, Zhong, Yuqiong, Wang, Xiaomin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327323/
https://www.ncbi.nlm.nih.gov/pubmed/37415240
http://dx.doi.org/10.1186/s13063-023-07482-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327323/
https://www.ncbi.nlm.nih.gov/pubmed/37415240
http://dx.doi.org/10.1186/s13063-023-07482-y

Ejemplares similares